THE HOOK
Heidi Health just raised $340 million to stop being a fancy note-taker and start acting like a supervised clinical teammate.
THE GIST
Melbourne-based Heidi closed $100M Series C led by Blackbird plus $240M from General Catalyst — $340M total — to scale its AI Care Partner across health systems, per SiliconANGLE. CEO Thomas Kelly wants agents completing real clinical work under oversight, as AMA data shows 81% of US physicians used augmented AI in 2026.
THE TAKE
Ambient scribes were the gateway drug; agents that touch workflows are the actual product. Hospitals will buy capacity theatre until liability docs catch up. $340M says VCs think admin burden is still the soft underbelly. The headache is trust: one bad agentic order and the procurement freeze writes itself.
OPINION
Physician AI adoption doubling since 2023 is real demand, not slideware — but caution on clinical judgment is the constraint money cannot erase. Heidi's human-in-the-loop pitch is why buyers listen, as covered by SiliconANGLE. Watch which US systems put agents on production clinical tasks.
- Story type: Important story
- Impact: Medium
- Confidence: High (official announcement)
- Audience: Business
- What changed: Heidi Health raised $340M (Series C + growth) to deepen AI agent adoption in care settings
- What to watch: Which U.S. systems put agents on production clinical tasks under supervision
- Reading time: 2 minutes
